Recurrence · adults (> 18 years of age) with trigger finger
It is very uncertain whether NSAID injection changes recurrence at 12 to 24 weeks compared with glucocorticoid injection (very low certainty).
1 finding from 1 review
Total active motion · adults (> 18 years of age) with trigger finger
1 finding from 1 review
Post-operative pain (residual pain, any severity) · adults (> 18 years of age) with trigger finger
NSAID injection showed no clear difference in residual pain compared with glucocorticoid injection (low certainty).
1 finding from 1 review
Global assessment of treatment success · adults (> 18 years of age) with trigger finger
NSAID injection showed no clear difference in participant‐reported treatment success compared with glucocorticoid injection (low certainty).
1 finding from 1 review
Adverse events · adults (> 18 years of age) with trigger finger
It is very uncertain whether NSAID injection changes adverse events compared with glucocorticoid injection (very low certainty).
1 finding from 1 review
Intervention not reported
Early acute postoperative pain (within 6 hours postoperatively using a validated pain scale: 0, no pain to 10, maximum pain) · adults undergoing surgery
1 finding from 1 review
Intervention not reported
Nausea and vomiting (1‐6 hours postoperatively) · adults undergoing surgery
The intervention showed no clear difference in nausea and vomiting (1‐6 hours postoperatively) (low certainty).
1 finding from 1 review
Intervention not reported
Nausea and vomiting (6‐48 hours postoperatively) · adults undergoing surgery
The intervention showed no clear difference in nausea and vomiting (6‐48 hours postoperatively) (low certainty).
1 finding from 1 review
Intervention not reported
Late acute postoperative pain (24‐48 hours postoperatively using a validated pain scale: 0, no pain to 10, maximum pain) · adults undergoing surgery
1 finding from 1 review
Intervention not reported
24‐hour morphine consumption (mg) · adults undergoing surgery
1 finding from 1 review
Intervention not reported
Time to first analgesic request (mean time in minutes) · adults undergoing surgery
1 finding from 1 review
Intervention not reported
Adverse events · adults undergoing surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Nausea and vomiting (1‐6 hours postoperatively) · adults undergoing surgery
The intervention showed no clear difference in nausea and vomiting (1‐6 hours postoperatively) (low certainty).
1 finding from 1 review
Intervention not reported
Nausea and vomiting (6‐48 hours postoperatively) · adults undergoing surgery
The intervention showed no clear difference in nausea and vomiting (6‐48 hours postoperatively) (low certainty).
1 finding from 1 review
Intervention not reported
Late acute postoperative pain (24‐48 hours postoperatively using a validated pain scale: 0, no pain to 10, maximum pain) · adults undergoing surgery
1 finding from 1 review
Intervention not reported
24‐hour morphine consumption (mg) · adults undergoing surgery
1 finding from 1 review
Intervention not reported
Time to first analgesic request (mean time in minutes) · adults undergoing surgery
1 finding from 1 review
Intervention not reported
Early acute postoperative pain (within 6 hours postoperatively using a validated pain scale: 0, no pain to 10, maximum pain) · adults undergoing surgery
1 finding from 1 review
Intervention not reported
Adverse events (Re‐operation for bleeding (reoperation for major bleeding within 30 days (yes/no))) · adults undergoing surgery
It is very uncertain whether the intervention changes adverse events (Re‐operation for bleeding (reoperation for major… (very low certainty).
1 finding from 1 review
Incidence of breast hematoma · women undergoing breast surgery
NSAID showed no clear difference in incidence of breast hematoma compared with placebo (low certainty).
1 finding from 1 review